Telomerase expression on aortic wall endothelial cells is attenuated in abdominal aortic aneurysms compared to healthy nonaneurysmal aortas  by Dimitroulis, Dimitrios et al.
Telomerase expression on aortic wall endothelial
cells is attenuated in abdominal aortic aneurysms
compared to healthy nonaneurysmal aortas
Dimitrios Dimitroulis, MD, Athanasios Katsargyris, MD, Chris Klonaris, MD,
Efthymios D. Avgerinos, MD, Matrona Fragou-Plemenou, MD, Gregory Kouraklis, MD, and
Christos D. Liapis, MD, Athens, Greece
Objective: Linear chromosomes carry specific DNA structures at their ends called telomeres. The latter shorten with each
successive cell division making their length a marker of cell age. Telomerase prevents such telomere attrition by adding
back telomeric repeats at the telomere ends, thus playing an important role in cell aging. On the other hand, an abdominal
aortic aneurysm (AAA) represents an age-related degenerative disorder. The aim of the present study was to investigate
a potential correlation of telomerase expression with AAA formation.
Methods: Aortic wall tissue samples were collected from 49 patients (mean age, 63.8 4.4 years) with AAAs during open
elective repair and from 24 deceased organ donors as controls (mean age, 60.5  3.9 years). Telomerase expression on
endothelial cells was detected by immunohistochemistry. Associations of telomerase positivity with AAAs and epidemi-
ologic and clinical variables were investigated.
Results: Telomerase expression was significantly decreased in patients with AAAs (11 of 49; 22.4%) compared to controls
(19 of 24; 79.2%; P < .001). This association persisted after adjustment for age, gender, coronary artery disease (CAD),
hypercholesterolemia, hypertension and smoking (odds ratio, 0.47; 95% confidence interval, 0.14-0.58; P < .01.).
Conclusion: Patients with AAAs have attenuated telomerase endothelial expression compared to controls, implying a
protective role of telomerase against AAA formation. Further investigation of pathways involved in vascular aging may
contribute to elucidation of AAA pathogenetic mechanisms. (J Vasc Surg 2011;54:1778-83.)
Clinical Relevance: Telomeres are special chromatin structures located at the ends of eukaryotic chromosomes, which
shorten with each cell division, thus reflecting cell age. Cells compensate for such a telomere loss by producing telomerase,
a reverse transcriptase that adds back telomeric repeats at the telomere ends. Telomerase is considered a key enzyme
modulating cell aging, and several studies have associated telomerase function with cardiovascular diseases such as
hypertension, atherosclerosis, and stroke. In the present study, telomerase endothelial expression was found to be
significantly attenuated in patients with AAAs compared to controls exerting a protective effect against AAA formation.
These results are of potential clinical value because they justify further investigation of telomerase expression and possible
association with AAAs in more accessible sites (ie, peripheral blood cells) for defining predisposition for AAAs and other
diagnostic purposes. In addition, our preliminary data could be potentially useful in the development of telomerase-
based treatment modalities for AAAs in the future. For example, maintenance of a youthful phenotype for
endothelial cells through preserved telomerase expression might provide a rationale for novel therapeutic strategies
in the AAA territory.
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tAbdominal aortic aneurysm (AAA) represents an age-
related vascular pathology with significant morbidity and
mortality.1 Indeed, recent studies suggest that biological
aging of the aortic wall may play an important role in AAA
pathophysiology.2 Telomere length has been described as a
potential biomarker of age-related diseases as well as a
marker of aging at the cellular level.3,4 Telomeres are
Athens University Medical School, 2nd Surgical Department, Vascular
Division, Laikon University General Hospital.
Competition of interest: none.
Reprint requests: Athanasios Katsargyris, MD, Athens University Medi-
cal School, 2nd Surgical Department, Vascular Division, Laikon Uni-
versity General Hospital, 17 Agiou Thoma Street, 11527 Athens,
Greece (e-mail: kthanassos@yahoo.com).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00e
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.06.079
1778pecial chromatin structures made up of a string of
TAGGG repeats that are located at the ends of eukaryotic
hromosomes aiming to safeguard gene integrity during
itosis by preventing DNA degradation at chromosomal
nds.4-7 Telomere length shortens with each cell division;
he difference between initial telomere length and short-
ned telomere length at a specific time point can be used to
stimate the biological age of the cell thus giving to the
elomere length a “mitotic clock” role reflecting cellular
urnover.3 This telomere length shortening occurs until a
ritical length beyond which mitosis is ceased because a
nite number of cell division has been reached. This cell
ivision-limiting mechanism is described as the “Heyflick
imit”2,5 and is considered to be a protective mechanism
gainst genomic instability and malignancy development in
ged cells.4 To prevent such telomere attrition, cells pro-
uce the enzyme “telomerase,” which is a reverse transcrip-
ase and can add back telomeric repeats at the telomere
nds, compensating for telomere loss.8
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Volume 54, Number 6 Dimitroulis et al 1779Interestingly, telomerase activity seems to play a critical
role in cell aging, and several studies have associated telom-
erase function with cardiovascular diseases such as hyper-
tension, atherosclerosis, and stroke.9-11 Moreover, absence
of telomerase activity has been correlated with endothelial
aging in several experimental systems in vivo and in vitro.12
AAA is considered an age-related degenerative vascular
disease with increased cell apoptosis and, therefore, telom-
erase activity could theoretically be altered compared to
healthy nonaneurysmal aorta. Given the importance of
early detection of AAAs and the need for specific biomarker
development, we investigated the potential role of telom-
erase in the pathogenesis of AAAs. We therefore compared
the expression of telomerase in endothelial cells of AAAs vs
nonaneurysmal aortic tissue from deceased organ donors.
Additional potential correlations of telomerase expression
with clinical and epidemiologic variables were also exam-
ined.
METHODS
Subjects. Tissue samples of an aneurysmal aorta were
obtained from 49 consecutive patients that underwent
AAA elective open repair in our department. Inclusion
criteria for these patients were age 65 years, infrarenal
abdominal aortic maximal diameter5 cm, and absence of
either clinical or imaging suspicion of free, impending, or
contained rupture that was also confirmed intraoperatively.
The study was approved by theHospital Ethics Committee,
and written informed consent was obtained from all partic-
ipants.
At entry into the study, a complete medical history, risk
factors, and medication intake were recorded, including
age, gender, coronary artery disease (CAD; angina pectoris,
myocardial infarction, coronary artery bypass grafting, per-
cutaneous transluminal coronary angioplasty), diabetes
mellitus (controlled with diet, oral hypoglycemic agents or
insulin; fasting glucose level 126 mg/dL), hypercholes-
terolemia (total cholesterol 200 mg/dL), hypertension
(systolic blood pressure 140 mm Hg, diastolic blood
pressure 90 mm Hg, or self-report of high blood pres-
sure),13 and smoking history. Statin treatment (regular
statin intake for4 weeks preoperatively) as well as positive
family history of AAAs in a first-degree relative were also
recorded. Control aortic samples were collected from 24
heart-beating deceased organ donors.
The absence of atherosclerotic changes and aneurysmal
dilation of the aorta on these subjects was confirmed mac-
roscopically during the organ removal operation as well as
during histologic examination performed before immuno-
histochemistry. Donors were selected by the National
Transplant Organization. Written informed consent was
obtained from families of all deceased organ donors in-
cluded in this study.
TISSUE SAMPLING
All aneurysm samples were obtained during elective
AAA repair. Tissue samples were retrieved after aortic
clamping from the anterior or lateral aortic wall, close to the coint of maximum dilatation of the AAA sac. Tissue sam-
ling from the posterior wall was avoided, because it was
onsidered to add to the risk of surgery.
All control samples (nonaneurysmal aortic wall sam-
les) were obtained during a laparotomy for cadaveric
rgan removal at a level below the renal arteries, which
epresents a comparable region and a similar procedure as
he AAA samples. In both cases (AAAs and controls), the
dventitia of the specimens was dissected free of excess
erivascular fat and surrounding soft tissues. The whole
hickness of the aortic wall, including the aneurysmatic
esion was examined. In cases with increased wall thickness,
he specimen was divided in two histologic sections labeled
A) for the interior part of the wall (lumen) and (B) for the
xterior part of the wall. The thrombus was extracted from
he vessel wall and examined in a different histologic sec-
ion, labeled (C).
From each patient/deceased donor, three different
amples were obtained to look for variations of telomerase
xpression within the same individual. In case of differences
mong the three samples with regard to telomerase positiv-
ty, the latter was defined by the majority of the samples (ie,
he two same samples; eg, in case of two positive and one
egative ¡ positive, in case of two negative and one
ositive¡ negative).
MMUNOHISTOCHEMISTRY
Aortic wall tissue samples were collected and fixed in
0% neutral buffered formaldehyde solution and embed-
ed in paraffin. Telomerase expression in endothelial aortic
ells was examined by immunohistochemistry in tissue sec-
ions of 4 m. Immunohistochemical staining was per-
ormed by the same pathologist in the same laboratory
ccording to the antibody manufacturer’s instructions. We
sed a mouse anti-human telomerase monoclonal antibody
Alpha Diagnostic International, San Antonio, Tex), which
as been widely used for immunohistochemical staining of
elomerase. The evaluation of the staining was done after
locking nonspecific staining of this particular peptide.
Antigen retrieval was performed by boiling slides in
itrate buffer (pH  6) in a microwave oven for 5  3
inutes. Incubation with the monoclonal telomerase (1:
0) antibody was performed overnight at 4°C. The immu-
ostaining was performed by using the KWIK KIT from
hermoShandon Limited, (Pittsburgh, Pa). The first step
as incubation with a polyvalent followed by incubation
ith a biotinylated anti-mouse secondary antibody and the
ultilink biotin-streptavidin-amplified detection system.
taining was visualized using a Fast Red Chromogen sys-
em and counterstaining with hematoxylin.
The expression of telomerase was examined on endo-
helial cells (ECs) of the aortic specimens by two different
bservers blinded to the clinical data in several optical
elds.10 Each aortic specimenwas considered “positive” for
elomerase on ECs when more than 5% of the homologous
ells were stained.14
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The t test was used for comparisons of continuous
variables between the groups of interest. The 2 test was
used for categorical variable comparisons. Factors signifi-
cant for AAA formation by univariate analysis (P  .05)
were assessed using multiple logistic regression analysis.
The interobserver agreement was determined with the use
of  statistics. The k value is indicated, including the SE,
statistical significance was set at P  .05, and all statistical
tests were two-tailed. Statistical analysis was performed
with SPSS 15.0 software (SPSS, Chicago, Ill).
RESULTS
Patients’ and deceased organ donors’ demographic
characteristics and cardiovascular risk factors are shown in
the Table. Mean age of patients with AAAs was 63.8 4.4
years, while the mean age of deceased organ donors was
60.5  3.9 years (P  .05). Male individuals represented
65.3% and 66.7% of AAAs and deceased donor cohorts,
respectively. Maximum AAA diameter ranged from 5.0 to
8.0 cm with a mean value of 5.8 cm. Smoking rates were
slightly elevated in AAAs compared to the control group,
but this difference did not reach statistical significance
(73.5% and 62.5%, respectively). Univariate analysis with
the t test and the 2 test applied appropriately revealed
statistical significant associations of AAAs with age (P 
.05), CAD history (P  .001), hypercholesterolemia (P 
.009), and hypertension (P  .001). Interobserver agree-
ment in terms of immunohistochemistry evaluation was
very good (  0.94; SE, 0.039).
EC telomerase immunohistochemical expression was
detected in 11 of 49 patients with AAAs and in 19 of 24
deceased organ donors (22.4% vs 79.2%, respectively; P 
.001) representing a significant decrease in telomerase ex-
pression in patients with AAAs compared with healthy
Table. Patient demographics and clinical characteristics
AAA
(n  49)
Nonaneurysmal
aortic control
(n  24) P value
Age, (mean  SD), years 63.8  4.4 60.5  3.9  .05
Gender (male), n (%) 32 (65) 16 (67) NS
Hypertension, n (%) 28 (57) 4 (17)  .001
Diabetes, n (%) 13 (27) 3 (13) NS
CAD, n (%) 22 (45) 0  .001
Hypercholesterolemia, n
(%) 21 (43) 3 (13) .009
Current smoking, n (%) 36 (74) 15 (63) NS
Statin therapy, n (%) 22 (45) 5 (21) NS
Antiplatelet therapy, n
(%) 17 (35) 3 (13) NS
Maximum AAA diameter,
mean (range), cm 5.8 (5-8) — —
Positive family AAA
history, n (%) 6 (12) 2 (8) NS
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; NS, not
significant.nonaneurysmal aortas of deceased donors (Fig). Variation wf telomerase expression within the same individual was
onsidered insignificant; only in three of 73 cases there was
difference in telomerase expression among the three
btained samples. In multiple logistic regression analysis
djusting for age, gender, CAD, hypercholesterolemia, hy-
ertension, and smoking, telomerase expression exerted an
ndependent significant protective effect against AAA for-
ation (odds ratio, 0.47; 95% confidence interval, 0.14-
.58; P  .01).
ISCUSSION
In this study, we aimed to assess the potential role of
elomerase activity on AAA formation by comparing the
mmunohistochemical expression of the enzyme on ECs of
AA vs healthy nondilated aortic wall. Interestingly, we
ave shown that patients with an AAA have an absolute
eduction of 55% in aortic wall telomerase expression com-
ared to controls with healthy nonaneurysmal aortas. This
ifference in telomerase expression between AAAs and
ontrols was independent of other confounding factors
uch as age, CAD, hypercholesterolemia, and hypertension,
mplying that telomerase may exert a protective effect
gainst AAA formation. To our knowledge, such an asso-
iation between AAA and aortic wall telomerase expression
as not been previously reported.
AAA has been already recognized as an age-related
egenerative vascular disease.1 Cell aging is characterized
y a progressive reduction of specific DNA protein struc-
ures located at the ends of eukaryotic chromosomes called
elomeres. The latter preserve genome integrity and stabil-
ty by preventing the recognition of chromosomal ends as
ouble-stranded DNA breaks.15,16 Currently, telomere at-
rition is considered a significant factor impairing somatic
ell proliferation and viability thus affecting organismal
ging.15 The synthesis of telomeric DNA in order to com-
ensate for this telomere attrition requires the activity of
elomerase, a specialized telomere-associated enzyme,
hich provides a template for new telomere synthesis.15,17
hus, unraveling molecular mechanisms involved in vascu-
ar aging, including telomerase and telomere-associated
athways could contribute to better understanding of the
athophysiology of AAAs.
Our findings are in line with previously published stud-
es that have linked telomere length and aortic disease.
kuda et al18 investigated telomere length in biopsies from
onaneurysmal human aorta and found significant differ-
nces in telomere attrition between proximal suprarenal
nd distal infrarenal aorta.More specifically, distal aorta was
haracterized by a higher rate of telomere shortening com-
ared to proximal aorta reflecting probably the enhanced
ellular turnover rate due to increased shear wall stress in
his vascular segment. Moreover, Wilson et al19 compared
elomere length in AAA biopsies and nonaneurysmal ab-
ominal aortas obtained from deceased organ donors; in-
erestingly, telomere genomic DNA content was found
ignificantly reduced in wall biopsies of AAA vs normal
orta, independently of patient age and gender. Similarly, it
as recently shown that peripheral blood leukocyte telo-
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with the latter being significantly increased by telomere
shortening.7
The above studies have linked telomere attrition with
AAA formation, which theoretically could be due to atten-
uated telomerase activity. To our knowledge, no other
study has investigated the telomerase expression on endo-
thelial cells of both AAAs and nonaneurysmal aortas. By
revealing such an association of attenuated telomerase ac-
tivity with AAA formation, the present study implies a
“telomerase-dependent” telomere shortening in AAAs.
The latter has not been previously shown in the AAA
territory.
The reduced telomerase expression in AAAs is biolog-
ically reasonable; AAA is well recognized as an age-related
vascular pathology,1 while mounting evidence suggests
that alterations in telomerase activity may play a role in the
pathogenesis of vascular aging.20 Arterial stiffening as-
sessed by increased pulse wave velocity represents an impor-
tant aspect of vascular aging; interestingly, alterations in
telomerase enzymatic activity have been recently found to
be associated with increased pulse pressure, a marker of
arterial aging.20 Thus, telomerase may have a key role in an
age-related degenerative mechanism of AAA formation.
Moreover, there is some evidence supporting the con-
tribution of oxidative stress in the pathogenesis of AAAs
both in animal and human studies.21-23 Notably, oxidative
stress seems to be also associated with telomere length and
telomerase activity. More specifically, due to its high GGG
content, telomeric DNA is susceptible to oxidative damage
and the generation of single strand breaks.24 Additionally,
reactive oxygen species inhibit telomerase expression and
activity accelerating telomere loss during replication and
promote its translocation from the nucleus to the cyto-
plasm,25 thus preventing the enzyme from accessing the
telomere.26,27 The above taken together implicate that
telomeres and their regulatory enzyme telomerase may be
linked to the AAA pathophysiology through oxidative
stress-mediated pathways.
Finally, telomerase may be linked to AAA development
Fig. Telomerase endothelial expression in abdominal a
walls. Note the significantly reduced telomerase expressiothrough mediation of endothelial senescence. The latter aefers to a permanent growth arrest of mitotically compe-
ent diploid cells that represent a DNA damage response
aused by telomere erosion due to inhibition of telomerase
ctivity.24,28 Senescent cells undergo distinct changes in
ene expression that significantly impair their functions.
C senescence in particular is associated with several phe-
otypic alterations including overexpression of inflamma-
ory mediators as well as extracellular matrix degrading
nzymes.29-31 Given that both inflammation and extracel-
ular matrix remodeling are considered to be implicated in
he AAA pathogenesis,32,33 telomerase-mediated endothe-
ial senescence may contribute to AAA formation.
Beyond the above hypotheses that require further re-
earch in order to be validated, our findings are of potential
linical value, because they suggest that among patients of a
pecific age group, those with attenuated telomerase aortic
ndothelial cell expression are more likely to have an AAA.
his could be of clinical significance given the need for
evelopment of novel biomarkers that could contribute to
arly AAA detection. Although currently aortic wall telom-
rase expression is not practical, our data support further
nvestigation of telomerase expression and possible associ-
tion with AAAs in more accessible sites (ie, peripheral
lood cells) for defining predisposition for AAAs and/or
ther diagnostic purposes. Besides, the fact that telomerase
s reduced in AAAs could be potentially useful in the
evelopment of telomerase targeting treatment modalities
or AAAs. For example, maintenance of a youthful pheno-
ype for endothelial cells through preserved telomerase
xpression might provide a rationale and strategy for ther-
peutic interventions in the AAA territory.
It is of note that both telomere length and telomerase
ave been previously correlated with several cardiovascular
iseases. Atherosclerosis seems to be linked with vascular
ging mediated partially by telomere shortening and cell
enescence; indeed, a characteristic senescent phenotype is
bserved in the endothelium of atherosclerotic lesions,
hile telomerase transduction prevents endothelial replica-
ive senescence in human aortic EC cultures. Moreover,
ounting evidence suggests that alterations in telomerase
aneurysms (AAAs) and control nonaneurysmal aortic
AAA specimens compared to control aortas (P  .001).orticctivity and telomere shortening may play a role in the
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December 20111782 Dimitroulis et alpathogenesis of hypertension; of note, mice deficient in
telomerase activity develop hypertension as a result of an
increase in plasma endothelin-1 plasma levels.34 In addi-
tion, telomerase activity and telomere length seem to also
play a role in the pathogenesis of CAD as indicated by Satoh
et al35 who showed that both telomere length and telom-
erase activity of endothelial progenitor cells were signifi-
cantly lower in patients with CAD than in controls. Thus,
telomerase seems to mediate several pathways related to
cardiovascular disease. Our study contributes to the current
literature by linking telomerase with AAAs, which repre-
sents an additional phenotype of cardiovascular pathology.
Several limitations of this study should be addressed.
Age was lower in the control group compared with the
AAA cohort. Given that age may alter telomerase expres-
sion, such a difference could have affected our results.
However, mean ages within the two groups differed only by
3 years, which represents a relatively small time period to
justify such a significant attenuation of telomerase expres-
sion due to age progression; besides, CAD and hyperten-
sion incidence were also significantly higher among patients
with AAAs and that may have also affected our results.
Although in multiple logistic regression analysis adjusting
for age, CAD, and hypertension, negative telomerase ex-
pression was found to be independently associated with
AAA formation; the possibility that these as well as other
unrecognized factors may have acted as confounders can-
not be completely excluded in our study. An internal con-
trol (telomerase expression of nonaneurysmal aortic wall in
the AAA group) could contribute to confirming that te-
lomerase expression attenuation is specific to the aneurys-
mal wall; however, taking samples of normal aorta from
patients with an AAA was considered to add to the risk of
surgery and, therefore, it was avoided. Despite the afore-
mentioned limitations, our results provide for the first time
some preliminary evidence that AAAs may be associated
with telomerase expression. Further investigation with
larger prospective studies with paired-matched cohorts is
necessary.
In conclusion, telomerase expression on endothelial
cells has been shown to be associated with AAA existence.
Specifically, EC telomerase expression was significantly
lower in patients with AAAs compared to controls. These
data, although preliminary, provide important information
regarding the role of vascular aging in the AAA pathogen-
esis. Further investigation is warranted.
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